查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701377

橫向流動化驗市場規模、佔有率、趨勢分析報告：按產品、方法、最終用途、測試、最終用途、地區、細分市場預測，2025-2030 年

Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits, Lateral Flow Readers), By Technique (Sandwich Assays, Competitive Assays), By Application, By Test, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 176 Pages | 商品交期: 2-10個工作天內

價格

橫向流動化驗市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球橫向流動化驗市場規模預計到 2030 年將達到 136 億美元，2025 年至 2030 年的複合年成長率為 5.99%。

推動成長的關鍵因素包括感染疾病病率的不斷上升、政府遏制感染疾病和慢性病的舉措不斷增多、對就地檢驗的需求不斷增加以及戰略併購數量的不斷增加。

橫向流動化驗是在近半個世紀前開發的，並促進了醫療保健、食品和飲料測試以及環境測試等領域的多種診斷和測試應用。同樣，橫向流動化驗在照護現場診斷的應用也在不斷擴大，在開發評估尿液和唾液等體液的產品方面取得了重大研究進展。

使用這些設備可以方便進行自我測試，減少實驗室測試的需要，並且無需訓練有素的測試負責人。儘管近年來實驗室檢測技術取得了一些進步，但一些新興國家仍面臨及時醫療干預的挑戰。這是鼓勵採用試紙和橫向流動化驗以促進及時診斷和治療的主要動力。

自疫情爆發以來，橫向流動化驗在家庭使用和自我檢測中的效用越來越廣泛，導致推出了多種家庭檢測方法。例如，市面上可用的測試包括雅培的 BinaxNOW COVID-19 抗原自我測試、Access Bio 的 CareStart COVID-19 抗原家庭測試、Becton, Dickinson and Company 的 BD Veritor 家用 COVID-19 測試和 Ellume 的 COVID-19 家庭測試。

政府支持使用此類測試的舉措預計將增加橫向流動化驗的採用，並促進橫向流動化驗市場的成長。例如，拜登-哈里斯政府正在向健康計劃和保險公司提供激勵措施，在全國範圍內建立檢測點網路，為擁有私人健康保險的人們提供免費的、在家的、非處方的 COVID-19 檢測。

領先企業和新興企業為開發和推出先進產品所採取的持續策略舉措預計將顯著推動市場成長。例如，2021 年 11 月，IUL SA 推出了一款新的側向流讀取儀iPeak Europium，用於掃描螢光標記的橫向流動測試。同樣在 2021 年 3 月，該公司宣布推出一款新的側向流讀取儀iPeak+。

此外，2021 年 1 月，總部位於英國的 Sensyne Health 推出了一款創新的智慧型手機應用程式 MagnifEye，該應用程式採用深度機器學習 AI 來自動解釋橫向流動診斷測試。預計市場參與者之間日益增多的合併和聯盟將促進新型橫向流動技術的獲得。

例如，2022 年 2 月，美國BD（Becton, Dickinson & Company）和 Scanwell Health 合作開發了一種 SARS-CoV-2 快速家用檢測試劑盒，採用 BD 橫向流動抗原檢測試劑盒和 Scanwell Health 行動應用程式。此次合作旨在提供高效、可擴展的快速抗原居家檢測解決方案。

除了無需等待測試結果解釋之外，使用橫向流動裝置還可以幫助最佳化及時的治療決策，提高治療的有效性，並顯著降低診斷成本，特別是在資源貧乏、測試基礎設施不足的地區。全球分散測試的趨勢對於增加全​​球橫向流動裝置的採用至關重要。

它們在控制瘧疾、流感等重大感染疾病發揮的作用也得到了證實。根據世衛組織介紹，快速診斷檢測可用於顯微鏡服務以外的衛生專業人員的診斷、54個瘧疾流行國家的專家的遠距離診斷以及疫情調查和寄生蟲流行情況監測。因此，橫向流動裝置提供的各種優勢是增加橫向流動化驗在全球範圍內採用的主要因素之一。

另一方面，PCR和分子診斷等先進技術的出現可能在一定程度上阻礙了橫向流動化驗的需求。橫向流動化驗具有較高的特異性和敏感性，但 PCR 和其他分子診斷技術較敏感。

橫向流動化驗市場報告重點

  • 到 2024 年，套件和試劑將佔據 35.43% 的絕對市場佔有率。這些產品可用於製藥、動物保健、環境測試、飼料和食品測試以及作物和植物測試。
  • 預計領先公司推出的新型自我檢測套組和家用套件將在預測期內推動市場成長。例如，2021 年 7 月，雅培實驗室在印度推出了 Panbio COVID-19 抗原自檢產品，隨後羅氏診斷印度公司於 2022 年 1 月推出了 COVID-19 家用檢測產品。
  • 2024年，由於感染疾病激增以及對快速準確檢測套組的需求不斷增加，臨床檢測領域推動了市場的發展。由於橫向流動化驗使用方便、便於攜帶，因此在許多診斷實驗室中都用於臨床測試。與其他臨床測試相比，這些測試可以在更快的時間內提供結果。此外，隨著口腔液體檢測的逐漸發展，橫向流動化驗由於檢體的非侵入性而變得方便。
  • 夾心檢測法因其高精度、具成本效益和易於使用的特點，在 2024 年佔據了全球市場主導地位。這些檢測可以在資源匱乏的醫療環境中進行，無需事先訓練。因此，夾心試驗被廣泛應用並推動成長。
  • 2024 年全球市場將以橫向流免疫測量細分市場為主導。這些檢測方法可用於檢測臨床樣本中的抗原或抗體，提供符合 WHO ASSURED 診斷標準的有效診斷選擇。近年來，對就地檢驗的需求不斷增加，預計在預測期內對此類檢測的需求還會成長。
  • 2024 年，醫院和診所部門佔據了相當大的市場佔有率。這些初級保健環境對於各種醫療狀況的診斷、治療和管理仍然至關重要。預計全球對具有增強診斷服務的醫院的需求不斷成長以及醫療保健支出不斷增加將推動市場成長。
  • 許多感染疾病，包括流感、愛滋病毒和肝炎，很容易在醫院傳播，並經常引起集體爆發。為了減少或消除這些感染疾病，醫院必須遵守特定的指導方針，以確保病患的適當隔離、醫護人員的安全和適當的消毒。
  • 由於流感等感染疾病率的上升，到2024年，北美將佔據絕對的銷售額佔有率，達到35.43%。例如，根據美國疾管中心估計，2010年至2020年間，美國每年約有900萬至4,100萬例流感感染病例，導致約14萬至71萬人住院，1.2萬至5.2萬人死亡。
  • 由於市場參與企業之間的合作日益增多以及各種傳染病檢查產品核可的不斷增加，預計亞太地區橫向流動化驗行業在預測期內將以最快的複合年成長率成長。例如，2020年2月，深圳易瑞生物科技宣布其COVID-19 LFA免疫測量套件已獲得CE標誌。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章橫向流動化驗市場變數、趨勢與範圍

  • 市場介紹/電網展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 橫向流動化驗市場分析工具
    • 波特分析
    • PESTEL分析
    • 管道
    • 案例研究

第4章橫向流動化驗市場：依產品分類的估計與趨勢分析

  • 橫向流動化驗市場：產品變異分析
  • 按產品 2024 年和 2030 年
  • 套件和試劑
  • 側向流讀取儀
    • 桌上型讀數儀
    • 數字領袖

第5章橫向流動化驗市場：按應用的估計和趨勢分析

  • 橫向流動化驗市場：應用變異分析
  • 按應用分類 2024 年和 2030 年
  • 臨床試驗
    • 傳染病檢查
    • 心臟標記檢測
    • 妊娠和生育能力測試
    • 膽固醇檢測/血脂分析
    • 藥物濫用檢測
    • 其他實驗室檢查
  • 獸醫診斷
  • 食品安全與環境檢測
  • 藥物開發和品質測試

第6章橫向流動化驗市場：依方法的估計與趨勢分析

  • 橫向流動化驗市場：方法學變異分析
  • 按 2024 年和 2030 年的方法
  • 夾心試驗
  • 競爭分析
  • 多重檢測分析

第7章橫向流動化驗市場：按測試進行估計和趨勢分析

  • 橫向流動化驗市場：測試變異性分析
  • 2024年及2030年檢查
  • 側流免疫檢測
  • 核酸橫向流動化驗

第8章橫向流動化驗市場：依最終用途的估計和趨勢分析

  • 橫向流動化驗市場：最終用途變異分析
  • 按 2024 年和 2030 年的應用
  • 醫院和診所
  • 診斷實驗室
  • 居家照護
  • 製藥和生物技術公司
  • 其他用途

第9章橫向流動化驗市場：區域估計與趨勢分析

  • 2024 年及 2030 年各地區橫向流動化驗市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • QuidelOrtho Corporation
    • F. Hoffmann-La Roche
    • DH Life Sciences, LLC.
    • Quest Diagnostics
Product Code: GVR-3-68038-880-0

Lateral Flow Assays Market Growth & Trends:

The global lateral flow assays market size is estimated to reach USD 13.60 billion by 2030, expanding at a CAGR of 5.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. Major factors driving the growth include the rising prevalence of infectious diseases, growing government initiatives to curb infectious and chronic diseases, rise in demand for point-of-care testing, and increasing strategic mergers & acquisitions among others.

Lateral flow assays were developed about half a century ago and have facilitated several diagnostic and testing applications in domains such as healthcare, food & beverage testing, and environmental testing. Similarly, lateral flow assay applications in point-of-care diagnostics are growing and are propelling significant advancements in research for the development of products that evaluate body fluids, such as urine and saliva.

The use of these devices promotes self-testing, reduces the need for laboratory testing, and eliminates the need for trained laboratory personnel. Although there have been several technological advancements in laboratory testing in the recent past, several emerging economies still face challenges regarding timely medical intervention. This represents a major factor that is driving the adoption of dipsticks or lateral flow assays for facilitating timely diagnosis and treatment.

Due to the increasing utility of lateral flow assays for home use and self-testing, several at-home tests were launched after the pandemic began. For instance, tests such as Abbott's BinaxNOW COVID-19 Antigen Self-Test, Access Bio's CareStart COVID-19 Antigen Home Test, Becton, Dickinson and Company's BD Veritor At-Home COVID-19 Test, and Ellume's COVID-19 Home Test are commercially available.

Government initiatives supporting the use of such tests are expected to enhance the penetration of lateral flow assays and can aid in driving the lateral flow assays market growth. For instance, the Biden-Harris administration has incentivized health plans and insurers for installing a network of locations across the country for providing at-home, over-the-counter COVID-19 tests for free to people with private health coverage.

Continuous strategic initiatives undertaken by leading and emerging players to develop and launch advanced products are anticipated to significantly support market growth. For instance, in November 2021, IUL SA launched the iPeak Europium, a new lateral flow reader used to scan fluorescence-labeled lateral flow tests. Similarly, in March 2021, the company introduced its new lateral flow reader, iPeak+.

Additionally, in January 2021, Sensyne Health, based in the U.K., introduced an innovative smartphone app-MagnifEye-that employs deep machine learning AI to automate the interpretation of lateral flow diagnostic tests. A rise in mergers and collaborations by market players is anticipated to facilitate access to novel lateral flow technologies.

For instance, in February 2022, U.S.-based BD (Becton, Dickinson and Company) and Scanwell Health collaborated to create an at-home rapid test for SARS-CoV-2 using a BD lateral flow antigen test and the Scanwell Health mobile app. The collaboration aims to provide an efficient and scalable rapid antigen home testing solution.

The use of lateral flow devices also eliminates the need to wait for deciphering test results as well as aids in the optimization of timely treatment decisions, improves the efficacy of care provided, and significantly reduces diagnosis costs, especially in areas with resource-constrained settings and insufficient laboratory infrastructure. The rising trend of decentralized testing has been crucial in increasing the adoption of lateral flow devices globally.

The role of these devices has also been observed in controlling major infectious diseases such as malaria and influenza. According to WHO, rapid diagnostic tests are used in diagnosis by healthcare professionals distant from microscopy services; remote diagnosis by professionals in malaria54-endemic countries; and outbreak investigation & survey of parasite prevalence. Thus, various benefits offered by lateral flow devices are among the key factors responsible for increasing the adoption of lateral flow assays globally.

On the other hand, with the advent of advanced technologies, such as PCR and molecular diagnostics, the demand for lateral flow assays may be witnessing sluggish growth to a certain extent. Although lateral flow assays have high specificity and sensitivity, PCR and other molecular diagnostic technologies have emerged to be more sensitive.

Lateral Flow Assays Market Report Highlights:

  • Kits & reagents dominated the market share of 35.43% in 2024. These products offer versatility for use in pharmaceuticals, animal health, environmental testing, feed & food testing, and crop & plant testing
  • The launch of new self-testing and at-home kits by major players is anticipated to boost market growth during the forecast period. For instance, in July 2021, Abbott Laboratories launched its Panbio COVID-19 Antigen Self-Test in India, which was followed by Roche Diagnostics India's launch of its COVID-19 At-Home Test in January 2022
  • In 2024, the clinical testing segment led the market, driven by a surge in infectious diseases and heightened demand for rapid, accurate test kits. Lateral flow assays are used in clinical testing by multiple diagnostic facilities due to ease of use & portability. These tests offer results with a reduced turnaround time as compared to other laboratory tests. In addition, as oral fluid-based testing is gradually developing, the use of lateral flow assays is becoming convenient because of the noninvasive nature of collecting specimens
  • Sandwich assays dominated the global market in 2024 due to their high accuracy, cost-effectiveness, and ease of use, owing to their affordability, accuracy, and ease of use. These assays can also be performed in low-resource healthcare settings without the need for prior training. As a result, sandwich assays are widely used, which drives the growth
  • The lateral flow immunoassay segment dominated the global market in 2024. These assays can be used for the detection of antigens or antibodies in clinical samples and offer an effective diagnostic option that conforms with the WHO ASSURED criteria for diagnostics. With increasing requirements for point-of-care testing alternatives in recent years, the demand for such assays is projected to grow over the forecast period
  • In 2024, the hospitals and clinics segment captured a significant market share, as these primary care settings remain essential for diagnosing, treating, and managing a wide range of medical conditions. The increasing need for hospitals with enhanced diagnostic services and rising global healthcare expenditure are anticipated to fuel market growth
  • Various infectious diseases, such as influenza, HIV, and hepatitis, are easily transmitted in hospitals, often causing outbreaks. To reduce or even eliminate such occurrences, hospitals have to comply with specific guidelines to ensure adequate patient quarantine measures, the safety of healthcare workers, and proper sanitization
  • North America held the dominant revenue share of 35.43% in 2024, owing to an increase in the incidence of infectious diseases such as influenza. For instance, as per the U.S. CDC estimates, between 2010 and 2020, there have been around 9 million to 41 million influenza infection cases, leading to about 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually in the U.S.
  • Asia Pacific lateral flow assays industry is anticipated to grow at the fastest CAGR over the forecast period owing to increasing collaborations among market entrants and a rise in product approval for various infectious disease tests is anticipated to boost the growth. For instance, in February 2020, Shenzen Bioeasy Biotechnology announced that the company received CE marking for its COVID-19 LFA immunoassay kits

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Lateral Flow Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of infectious diseases
      • 3.3.1.2. Technological advancements in lateral flow
      • 3.3.1.3. Growing adoption in homecare settings
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Stringent Regulations
    • 3.3.3. Market Opportunities Analysis
      • 3.3.3.1. Growing demand for Point-of-Care (POC) Testing
      • 3.3.3.2. Expanding applications beyond healthcare
    • 3.3.4. Market Challenges Analysis
      • 3.3.4.1. Product Recalls
  • 3.4. Lateral Flow Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
    • 3.4.3. Pipeline
    • 3.4.4. Case Study

Chapter 4. Lateral Flow Assay Market: Product Estimates & Trend Analysis

  • 4.1. Lateral Flow Assay Market: Product Movement Analysis
  • 4.2. Lateral Flow Assay Market Estimates and Forecasts, by Product 2024 & 2030 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lateral Flow Readers
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Benchtop Readers
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Digital Readers
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Lateral Flow Assay Market: Application Estimates & Trend Analysis

  • 5.1. Lateral Flow Assay Market: Application Movement Analysis
  • 5.2. Lateral Flow Assay Market Estimates and Forecasts, by Application 2024 & 2030 (USD Million)
  • 5.3. Clinical Testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Infectious Disease Testing
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. COVID-19
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Mosquito Borne Disease Testing
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Influenza Testing
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.5. Sexually Transmitted Infection Testing
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.2. HIV Testing
          • 5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.3. HPV Testing
          • 5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.4. Chlamydia Testing
          • 5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.5. Gonorrhea Testing
          • 5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.6. Syphilis Testing
          • 5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.2.5.7. Other STI Testing
          • 5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.6. Hepatitis
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.7. Tuberculosis
        • 5.3.2.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.8. Other Infectious Diseases
        • 5.3.2.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Cardiac Marker Testing
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.2. Troponin I and T Testing
        • 5.3.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.3. CK-MB Testing
        • 5.3.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.4. BNP and NT-Probnp Testing
        • 5.3.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.5. Myoglobin Testing
        • 5.3.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.6. D-Dimer Testing
        • 5.3.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.3.7. Other Cardiac Marker Tests
        • 5.3.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Pregnancy & Fertility Testing
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.4.2. Pregnancy Testing
        • 5.3.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.4.3. Fertility Testing
        • 5.3.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Cholesterol Testing/Lipid Profile
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Drugs of Abuse Testing
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Other Clinical Tests
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Veterinary Diagnostics
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Food Safety & Environment Testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Drug Development & Quality Testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Lateral Flow Assay Market: Technique Estimates & Trend Analysis

  • 6.1. Lateral Flow Assay Market: Technique Movement Analysis
  • 6.2. Lateral Flow Assay Market Estimates and Forecasts, by Technique 2024 & 2030 (USD Million)
  • 6.3. Sandwich Assays
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Competitive Assays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Multiplex Detection Assays
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Lateral Flow Assay Market: Test Estimates & Trend Analysis

  • 7.1. Lateral Flow Assay Market: Test Movement Analysis
  • 7.2. Lateral Flow Assay Market Estimates and Forecasts, by Test 2024 & 2030 (USD Million)
  • 7.3. Lateral Flow Immunoassay
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Nucleic Acid Lateral Flow Assay
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Lateral Flow Assay Market: End Use Estimates & Trend Analysis

  • 8.1. Lateral Flow Assay Market: End Use Movement Analysis
  • 8.2. Lateral Flow Assay Market Estimates and Forecasts, by End Use 2024 & 2030 (USD Million)
  • 8.3. Hospitals & Clinics
    • 8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Home Care
    • 8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Pharmaceutical & Biotechnology Companies
    • 8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Other End Use
    • 8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Lateral Flow Assay Market: Regional Estimates & Trend Analysis

  • 9.1. Lateral Flow Assay Market Share, By Region, 2024 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Competitive Scenario
      • 9.2.2.3. Regulatory Framework
      • 9.2.2.4. Reimbursement Scenario
      • 9.2.2.5. U.S. Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Competitive Scenario
      • 9.2.3.3. Regulatory Framework
      • 9.2.3.4. Reimbursement Scenario
      • 9.2.3.5. Canada Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Competitive Scenario
      • 9.2.4.3. Regulatory Framework
      • 9.2.4.4. Reimbursement Scenario
      • 9.2.4.5. Mexico Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. Reimbursement Scenario
      • 9.3.2.5. UK Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Reimbursement Scenario
      • 9.3.3.5. Germany Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Reimbursement Scenario
      • 9.3.4.5. France Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Competitive Scenario
      • 9.3.5.3. Regulatory Framework
      • 9.3.5.4. Reimbursement Scenario
      • 9.3.5.5. Italy Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Competitive Scenario
      • 9.3.6.3. Regulatory Framework
      • 9.3.6.4. Reimbursement Scenario
      • 9.3.6.5. Spain Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Competitive Scenario
      • 9.3.7.3. Regulatory Framework
      • 9.3.7.4. Reimbursement Scenario
      • 9.3.7.5. Denmark Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Competitive Scenario
      • 9.3.8.3. Regulatory Framework
      • 9.3.8.4. Reimbursement Scenario
      • 9.3.8.5. Sweden Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Competitive Scenario
      • 9.3.9.3. Regulatory Framework
      • 9.3.9.4. Reimbursement Scenario
      • 9.3.9.5. Norway Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. Reimbursement Scenario
      • 9.4.2.5. Japan Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Reimbursement Scenario
      • 9.4.3.5. China Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. Reimbursement Scenario
      • 9.4.4.5. India Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Reimbursement Scenario
      • 9.4.5.5. Australia Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Reimbursement Scenario
      • 9.4.6.5. South Korea Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Reimbursement Scenario
      • 9.4.7.5. Thailand Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Reimbursement Scenario
      • 9.5.2.5. Brazil Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. Reimbursement Scenario
      • 9.5.3.5. Argentina Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Reimbursement Scenario
      • 9.6.2.5. South Africa Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Reimbursement Scenario
      • 9.6.3.5. Saudi Arabia Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Reimbursement Scenario
      • 9.6.4.5. UAE Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Competitive Scenario
      • 9.6.5.3. Regulatory Framework
      • 9.6.5.4. Reimbursement Scenario
      • 9.6.5.5. Kuwait Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Abbott
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Bio-Rad Laboratories, Inc
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. Siemens Healthineers AG
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. BIOMERIEUX
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. BD
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. QIAGEN
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. QuidelOrtho Corporation
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. F. Hoffmann-La Roche
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives
    • 10.4.9. DH Life Sciences, LLC.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/ Strategic Initiatives
    • 10.4.10. Quest Diagnostics
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 Primary interview details: North America
  • Table 2 Primary interview details: Europe
  • Table 3 Primary interview details: Asia Pacific
  • Table 4 Primary interview details: Latin America
  • Table 5 Primary interview details: Middle East & Africa
  • Table 6 List of secondary sources
  • Table 7 List of abbreviation
  • Table 8 Lateral Flow Assay Market, SWOT Analysis, Internal and External Factors
  • Table 9 List of benchtop and mobile/digital readers available in the market
  • Table 10 North America lateral flow assay market, by country, 2018 - 2030 (USD Million)
  • Table 11 North America lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 12 North America lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 13 North America lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 14 North America lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 15 North America lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 16 North America lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 17 North America lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 18 North America lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 19 North America lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 20 North America lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 21 U.S. lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 22 U.S. lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 23 U.S. lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 24 U.S. lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 25 U.S. lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 26 U.S. lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 27 U.S. lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 28 U.S. lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 29 U.S. lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 30 U.S. lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 31 Canada lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 32 Canada lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 33 Canada lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 34 Canada lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 35 Canada lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 36 Canada lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 37 Canada lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 38 Canada lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 39 Canada lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Canada lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 41 Europe lateral flow assay market, by country, 2018 - 2030 (USD Million)
  • Table 42 Europe lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 43 Europe lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 44 Europe lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 45 Europe lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 46 Europe lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 47 Europe lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 48 Europe lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 49 Europe lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 50 Europe lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Europe lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 52 Germany lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 53 Germany lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 54 Germany lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 55 Germany lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 56 Germany lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 57 Germany lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 58 Germany lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 59 Germany lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 60 Germany lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Germany lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 62 UK lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 63 UK lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 64 UK lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 65 UK lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 66 UK lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 67 UK lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 68 UK lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 69 UK lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 70 UK lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 71 UK lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 72 France lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 73 France lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 74 France lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 75 France lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 76 France lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 77 France lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 78 France lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 79 France lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 80 France lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 81 France lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 82 Italy lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 83 Italy lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 84 Italy lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 85 Italy lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 86 Italy lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 87 Italy lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 88 Italy lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 89 Italy lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 90 Italy lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Italy lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 92 Spain lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 93 Spain lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 94 Spain lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 95 Spain lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 96 Spain lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 97 Spain lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 98 Spain lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 99 Spain lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 100 Spain lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Spain lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 102 Sweden lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 103 Sweden lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 104 Sweden lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 105 Sweden lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 106 Sweden lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 107 Sweden lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 108 Sweden lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 109 Sweden lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 110 Sweden lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Sweden lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 112 Denmark lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 113 Denmark lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 114 Denmark lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 115 Denmark lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 116 Denmark lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 117 Denmark lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 118 Denmark lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 119 Denmark lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 120 Denmark lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 121 Denmark lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 122 Norway lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 123 Norway lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 124 Norway lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 125 Norway lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 126 Norway lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 127 Norway lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 128 Norway lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 129 Norway lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 130 Norway lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 131 Norway lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 132 Asia Pacific lateral flow assay market, by country, 2018 - 2030 (USD Million)
  • Table 133 Asia Pacific lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 134 Asia Pacific lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 135 Asia Pacific lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 136 Asia Pacific lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 137 Asia Pacific lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 138 Asia Pacific lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 139 Asia Pacific lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 140 Asia Pacific lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 141 Asia Pacific lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 142 Asia Pacific lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 143 Japan lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 144 Japan lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 145 Japan lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 146 Japan lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 147 Japan lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 148 Japan lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 149 Japan lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 150 Japan lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 151 Japan lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 152 Japan lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 153 Japan lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 154 China lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 155 China lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 156 China lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 157 China lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 158 China lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 159 China lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 160 China lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 161 China lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 162 China lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 163 China lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 164 India lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 165 India lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 166 India lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 167 India lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 168 India lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 169 India lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 170 India lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 171 India lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 172 India lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 173 India lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 174 South Korea lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 175 South Korea lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 176 South Korea lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 177 South Korea lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 178 South Korea lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 179 South Korea lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 180 South Korea lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 181 South Korea lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 182 South Korea lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 183 South Korea lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 184 Australia lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 185 Australia lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 186 Australia lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 187 Australia lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 188 Australia lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 189 Australia lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 190 Australia lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 191 Australia lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 192 Australia lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 193 Australia lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 194 Thailand lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 195 Thailand lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 196 Thailand lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 197 Thailand lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 198 Thailand lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 199 Thailand lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 200 Thailand lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 201 Thailand lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 202 Thailand lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 203 Thailand lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 204 Latin America lateral flow assay market, by country, 2018 - 2030 (USD Million)
  • Table 205 Latin America lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 206 Latin America lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 207 Latin America lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 208 Latin America lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 209 Latin America lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 210 Latin America lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 211 Latin America lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 212 Latin America lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 213 Latin America lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 214 Latin America lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 215 Brazil lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 216 Brazil lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 217 Brazil lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 218 Brazil lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 219 Brazil lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 220 Brazil lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 221 Brazil lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 222 Brazil lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 223 Brazil lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 224 Brasil lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 225 Mexico lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 226 Mexico lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 227 Mexico lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 228 Mexico lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 229 Mexico lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 230 Mexico lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 231 Mexico lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 232 Mexico lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 233 Mexico lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 234 Mexico lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 235 Argentina lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 236 Argentina lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 237 Argentina lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 238 Argentina lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 239 Argentina lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 240 Argentina lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 241 Argentina lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 242 Argentina lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 243 Argentina lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 244 Argentina lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 245 MEA lateral flow assay market, by country, 2018 - 2030 (USD Million)
  • Table 246 MEA lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 247 MEA lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 248 MEA lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 249 MEA lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 250 MEA lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 251 MEA lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 252 MEA lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 253 MEA lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 254 MEA lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 255 MEA lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 256 South Africa lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 257 South Africa lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 258 South Africa lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 259 South Africa lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 260 South Africa lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 261 South Africa lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 262 South Africa lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 263 South Africa lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 264 South Africa lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 265 South Africa lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 266 Saudi Arabia lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 267 Saudi Arabia lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 268 Saudi Arabia lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 269 Saudi Arabia lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 270 Saudi Arabia lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 271 Saudi Arabia lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 272 Saudi Arabia lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 273 Saudi Arabia lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 274 Saudi Arabia lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 275 Saudi Arabia lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 276 UAE lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 277 UAE lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 278 UAE lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 279 UAE lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 280 UAE lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 281 UAE lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 282 UAE lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 283 UAE lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 284 UAE lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 285 UAE lateral flow assay market, by test, 2018 - 2030 (USD Million)
  • Table 286 Kuwait lateral flow assay market, by product, 2018 - 2030 (USD Million)
  • Table 287 Kuwait lateral flow assay market, by lateral flow readers, 2018 - 2030 (USD Million)
  • Table 288 Kuwait lateral flow assay market, by clinical Testing, 2018 - 2030 (USD Million)
  • Table 289 Kuwait lateral flow assay market, by infectious diseases testing, 2018 - 2030 (USD Million)
  • Table 290 Kuwait lateral flow assay market, by sexually transmitted infection testing, 2018 - 2030 (USD Million)
  • Table 291 Kuwait lateral flow assay market, by cardiac marker testing, 2018 - 2030 (USD Million)
  • Table 292 Kuwait lateral flow assay market, by pregnancy & fertility testing, 2018 - 2030 (USD Million)
  • Table 293 Kuwait lateral flow assay market, by technique, 2018 - 2030 (USD Million)
  • Table 294 Kuwait lateral flow assay market, by end use, 2018 - 2030 (USD Million)
  • Table 295 Kuwait lateral flow assay market, by test, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in Asia Pacific
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in Middle East & Africa
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Lateral Flow Assay Market Summary, 2020
  • Fig. 14 Parent Market Outlook
  • Fig. 15 Consumer behavior analysis
  • Fig. 16 COVID-19 cases worldwide*
  • Fig. 17 Lateral flow assays market driver impact
  • Fig. 18 Lateral flow assays market restraint impact
  • Fig. 19 Lateral flow assays market challenge impact
  • Fig. 20 Porter's five force analysis
  • Fig. 21 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 22 Lateral Flow market: Product Movement Analysis, (USD, Million)
  • Fig. 23 Lateral flow assays market: Segment dashboard
  • Fig. 24 Kits & Reagents Market, 2018 - 2030 (USD Million)
  • Fig. 25 Lateral Flow Readers market, 2018 - 2030 (USD Million)
  • Fig. 26 Benchtop Lateral Flow Readers Market, 2018 - 2030 (USD Million)
  • Fig. 27 Digital/Mobile Lateral Flow Readers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Lateral Flow market: Application Movement Analysis, (USD, Million)
  • Fig. 29 Lateral flow assays market: Segment dashboard
  • Fig. 30 Clinical Testing Market, 2018 - 2030 (USD Million)
  • Fig. 31 Infectious Disease Testing Market, 2018 - 2030 (USD Million)
  • Fig. 32 COVID-19 Testing Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mosquito-borne Disease Testing Market, 2018 - 2030 (USD Million)
  • Fig. 34 Influenza Testing Market, 2018 - 2030 (USD Million)
  • Fig. 35 Sexually Transmitted Infection Testing Market, 2018 - 2030 (USD Million)
  • Fig. 36 HIV Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 HPV Testing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Chlamydia Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Syphilis Testing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Gonorrhea Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Other STDs Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 Hepatitis Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Tuberculosis Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Other Infectious Disease Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Cardiac Marker Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Troponin I and T Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 CK-MB Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 BNP and NT-ProBNP Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Myoglobin Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 D-Dimer Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Other Cardiac Marker Tests Market, 2018 - 2030 (USD Million)
  • Fig. 52 Pregnancy & Fertility Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Pregnancy Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Fertility Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Cholesterol Testing/Lipid Profile Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Drugs of Abuse Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Other Clinical Tests Market, 2018 - 2030 (USD Million)
  • Fig. 58 Veterinary Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Food Safety & Environment Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Drug Development & Quality Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Lateral Flow market: Technique Movement Analysis, (USD, Million)
  • Fig. 62 Lateral flow assays: Segment dashboard
  • Fig. 63 Sandwich Assay Market, 2018 - 2030 (USD Million)
  • Fig. 64 Competitive Assay Market, 2018 - 2030 (USD Million)
  • Fig. 65 Multiplex Detection Assay Market, 2018 - 2030 (USD Million)
  • Fig. 66 Lateral Flow market: End Use Movement Analysis, (USD, Million)
  • Fig. 67 Lateral flow assays market: Segment Dashboard
  • Fig. 68 Hospitals and clinics market, 2018 - 2030 (USD Million)
  • Fig. 69 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 70 Home Care Market, 2018 - 2030 (USD Million)
  • Fig. 71 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • Fig. 72 Other End Users Market, 2018 - 2030 (USD Million)
  • Fig. 73 Lateral Flow market: Test Movement Analysis, (USD, Million)
  • Fig. 74 Lateral flow assays market: Segment Dashboard
  • Fig. 75 Lateral flow immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 76 nucleic acid lateral flow assay Market, 2018 - 2030 (USD Million)
  • Fig. 77 Lateral flow assays market: regional outlook
  • Fig. 78 Lateral Flow Assay Market Share, by region, 2024 & 2030 (%)
  • Fig. 79 U.S. lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Europe U.S. and Europe lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UK lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Germany lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 France lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Spain lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Italy lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Denmark lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Sweden lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Norway lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Market participant categorization
  • Fig. 99 Asia Pacific lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Market participant categorization
  • Fig. 101 China lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Market participant categorization
  • Fig. 103 Japan lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Market participant categorization
  • Fig. 105 Australia lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Market participant categorization
  • Fig. 107 India lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Market participant categorization
  • Fig. 109 South Korea lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Market participant categorization
  • Fig. 111 Thailand lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Market participant categorization
  • Fig. 113 Latin America lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 Market participant categorization
  • Fig. 115 Brazil lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Market participant categorization
  • Fig. 117 Argentina lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Market participant categorization
  • Fig. 119 Middle East and Africa lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Market participant categorization
  • Fig. 121 South Africa lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Market participant categorization
  • Fig. 123 Saudi Arabia lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 Market participant categorization
  • Fig. 125 UAE lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Market participant categorization
  • Fig. 127 Kuwait lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Market participant categorization
  • Fig. 129 Lateral Flow Assay Market, Heat Map Analysis, by Key Market Participants, 2024
  • Fig. 130 Strategy Framework
  • Fig. 131 Participant categorization